CRN.AXCRN.AXASX
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -47.20% | -54.45% | -53.68% | -44.62% | +6.31% |
| Gross Profit Growth | -76.59% | -105.13% | -75.66% | -99.20% | -120.37% |
| EBITDA Growth | +0.00% | -454.64% | -101.13% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | -101.13% | -401.30% | -530.86% |
| Net Income Growth | +0.00% | +0.00% | -212.45% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | -212.62% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | -212.90% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -0.00% | +0.00% | -0.00% | -0.00% | -0.00% |
| Weighted Average Shares Diluted Growth | -0.00% | +0.00% | -0.40% | +0.00% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -4.39% | +0.00% | -20.46% | +3729.18% | -323.92% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | -1249.09% |
| Receivables Growth | -46.00% | -63.78% | -63.40% | -60.29% | +25.53% |
| Inventory Growth | -44.73% | -41.32% | -39.51% | -10.02% | +25.40% |
| Asset Growth | -35.92% | -38.45% | -34.33% | -32.29% | +18.63% |
| Book Value per Share Growth | -41.31% | -46.59% | -51.34% | -53.56% | -39.40% |
| Debt Growth | +10.31% | +7.88% | +16.73% | +19.70% | +68.05% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -42.07% | -31.93% | -32.38% | -90.37% | -74.77% |